SCHEMBL2472676

SCHEMBL2472676

CC(C)(C)OC(=O)N1Cc2cc(C3(Cl)CCC(Oc4ccccc4F)CC3)ccc2-n2cnnc2C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.36
KDM1A O60341 1/20 0.36
PDE4B Q07343 4/20 0.34
PDE4A P27815 3/20 0.34
PDE4C Q08493 3/20 0.34
PDE4D Q08499 3/20 0.34
CACNB4 O00305 2/20 0.34
CACNA1A O00555 2/20 0.34
CACNA1G O43497 2/20 0.34
CACNG3 O60359 2/20 0.34
CACNA1F O60840 2/20 0.34
CACNA1H O95180 2/20 0.34
CACNB3 P54284 2/20 0.34
CACNA2D1 P54289 2/20 0.34
CACNG7 P62955 2/20 0.34
CACNA1B Q00975 2/20 0.34
CACNA1D Q01668 2/20 0.34
CACNB1 Q02641 2/20 0.34
CACNG1 Q06432 2/20 0.34
CACNB2 Q08289 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2469674 0.87 PDE4A (0.34) GPR119KDM1APDE4BPDE4APDE4C
SCHEMBL2473414 0.87 AVPR1A (0.38) AVPR1A
SCHEMBL2336519 0.86 DDB1 (0.35) GPR119PDE4BPDE4APDE4CPDE4D
SCHEMBL2469541 0.86 GPR119 (0.34) GPR119KDM1APDE4BPDE4APDE4C
SCHEMBL2336887 0.85 PDE4B (0.36) GPR119PDE4BPDE4APDE4CPDE4D
SCHEMBL2550063 0.85 NAMPT (0.40) GPR119KDM1AOXTRAVPR1ADDB1
SCHEMBL2472197 0.85 GPR119 (0.39) GPR119PDE4BPDE4APDE4CPDE4D
SCHEMBL2475380 0.85 GPR119 (0.35) GPR119KDM1APDE4BPDE4APDE4C
SCHEMBL2577744 0.85 OXTR (0.35) GPR119OXTRAVPR1ADDB1CRBN
SCHEMBL2474689 0.85 GPR119 (0.39) GPR119KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370441-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN VIA RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2011-10-05 EP claimed
WO-2010060836-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN VIA RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-06-03 WO claimed
EP-3035939-A1 V1A ANTAGONISTS TO TREAT PHASE SHIFT SLEEP DISORDERS F. Hoffmann-La Roche AG (CH) 2016-06-29 EP disclosed
WO-2015024819-A1 V1A ANTAGONISTS TO TREAT PHASE SHIFT SLEEP DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2015-02-26 WO disclosed
EP-2370441-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN VIA RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2011-10-05 EP disclosed
WO-2010060836-A1 ARYLCYCLOHEXYLETHERS OF DIHYDROTETRAAZABENZOAZULENES FOR USE AS VASOPRESSIN VIA RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2010-06-03 WO disclosed